Who is sponsoring NCT01149876?

NCT01149876 is sponsored by Massachusetts General Hospital.

What condition does NCT01149876 study?

NCT01149876 studies Hyperpigmentation.

What drugs are being tested in NCT01149876?

Interventions: Nu Skin Product, Cosmetic instrument, Tretinoin cream 0.05, CeraVe moisturizer.

What is the status of NCT01149876?

NCT01149876 is currently COMPLETED.

Last reviewed 2014-10-30 · How we verify

A Single Blind, Placebo Controlled Trial to Evaluate Effects of a Study Medication, a Nu Skin Lightening Product With and Without Iontophoresis vs Tretinoin Cream vs Vehicle Control for Facial Hyperpigmentation

NCT01149876 Phase 4 COMPLETED Results posted

The purpose of this study is to determine whether a topical Nu Skin product with or without a galvanic spa device improves brown spots on the face. The Nu Skin product will be compared to an over the counter moisturizer and tretinoin cream.

Details

Lead sponsor	Massachusetts General Hospital
Phase	Phase 4
Status	COMPLETED
Enrolment	80
Start date	2010-06
Completion	2011-12

Conditions

Hyperpigmentation

Interventions

Nu Skin Product
Cosmetic instrument
Tretinoin cream 0.05
CeraVe moisturizer

Primary outcomes

Change in Hyperpigmentation of the Face — baseline to 16 weeks
Primary outcome measure will be change in hyperpigmentation of baseline compared to week 16. Hyperpigmentation will be measured clinically using a 0-6 scale where 0 is no hyperpigmentation and 6 is very severe hyperpigmentation.

Countries

United States